2019

While the federal government continues to debate various policies for lowering prescription drug prices, many states have already…

The US Food and Drug Administration (“FDA”) recently issued four final guidance documents related to 510(k) medical device…

Step therapy, the requirement that more cost effective/inexpensive drugs and therapies must be prescribed for a patient before a…

On Thursday, November 7, 2019, Health and Human Services (HHS) Secretary Alex Azar spoke at the American Society of Nephrology…

In September 2019, District of Columbia Federal Judge Rosemary Collyer issued a court ruling that struck down the Trump…

Despite a ruling from a federal judge earlier this year, the United States Centers for Medicare and Medicaid Services (CMS) has…

As we reported in July, the Centers for Medicare and Medicaid Services (CMS) was proposing changes to the CME industry and Open…

On October 28, 2019, Allergan announced that its subsidiaries, several units of Forest Laboratories, have reached an agreement to…

Recently, the House Health, Employment, Labor and Pensions (“HELP”) Subcommittee held a hearing to consider testimony and discuss…

On October 25, 2019, the United States Attorney’s Office for the District of Massachusetts announced that two foundations, Chronic…